Antibiotics is a drug that has saved millions of lives annually since the discovery of penicillin and is a prerequisite for modern healthcare, but antibiotic resistance threatens its effectiveness. The World Health Organization (WHO) has estimated that 10 million people will die annually in 2050 if we fail to slow down the global increase in antibiotic-resistant bacterial infections. My research group and its network are trying to identify risk factors to suffer from a serious infection caused by antibiotic-resistant bacteria. We carry out evidence-based interventions against antibiotic resistance in low and high resistance environments, which means studies in the Nordic countries, Europe and Southeast Asia. At the same time, we carry out clinical studies in the highly specialized care in Sweden to ensure optimal antibiotic exposure in life-threatening infections with the least risk of treatment failure, resistance development and toxicity.
KP means that they are infected with CRE